Kirjojen hintavertailu – 12 859 829 kirjaa ja 27 kauppaa

Kirjailija

Vijay Sagar Madamsetty

Kirjat ja teokset yhdessä paikassa: 3 kirjaa, julkaisuja vuosilta 2021–2025, suosituimpiin kuuluu Nanocrystals in Cancer Theranostics. Vertaile teosten hintoja ja tarkista saatavuus suomalaisista kirjakaupoista.

3 kirjaa

Kirjojen julkaisuvuodet: 2021–2025.

Nanoparticles in Angiogenesis and Cancer

Nanoparticles in Angiogenesis and Cancer

Sudip Mukherjee; Vijay Sagar Madamsetty

Springer International Publishing AG
2022
sidottu
This book highlights recent developments of organic and inorganic nanomedicine that play a major role in anti-angiogenic cancer therapy. In addition, the authors present examples of nanomedicine based anti-angiogenic agents and their applications in cancer therapy. Angiogenesis is a pathophysiological phenomenon that modulates cell proliferation and cell migration and plays important roles in cancer. Anti-angiogenic nanotherapies have gained immense attention in recent times as alternative cost-effective therapies that opened a new dimension in cancer theranostics. Further the challenges of the anti-angiogenic nanotherapies and possible future perspective are detailed.
Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy

Emerging Trends in Immunomodulatory Nanomaterials Toward Cancer Therapy

Anubhab Mukherjee; Vijay Sagar Madamsetty

Springer International Publishing AG
2021
nidottu
Recently, immunomodulatory nanomaterials have gained immense attention due to their involvement in the modulation of the body’s immune response to cancer therapy. This book highlights various immunomodulatory nanomaterials (including organic, polymer, inorganic, liposomes, viral, and protein nanoparticles) and their role in cancer therapy. Additionally, the mechanism of immunomodulation is reviewed in detail. Finally, the challenges of these therapies and their future outlook are discussed. We believe this book will be helpful to a broad community including students, researchers, educators, and industrialists.